Sjögren’s Syndrome and Associations with Other Autoimmune and Rheumatic Diseases

  • James E. Peters
  • David A. Isenberg
Chapter
First Online:

Abstract

Sjögren’s syndrome (SS) is an autoimmune exocrinopathy that manifests itself most commonly as dryness of the mucosal surfaces. Systemic or extraglandular features can also occur. Both primary and secondary forms of SS are recognized to exist. In the latter, the syndrome develops in a patient with another systemic autoimmune disease such as rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). The secondary form of SS is the focus of this chapter. The current nomenclature struggles to classify patients with mixed features of SS and another autoimmune condition. The term “Sjögren’s overlap” has been proposed to describe such patients.

Keywords

Systemic Lupus Erythematosus Rheumatoid Arthritis Patient Systemic Lupus Erythematosus Patient Coeliac Disease Mixed Connective Tissue Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Theander E, Jacobsson LTH. Relationship of Sjögren’s syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am. 2008;34:935–47.PubMedCrossRefGoogle Scholar
  2. 2.
    Lazarus MN, Isenberg DA. Development of additional autoimmune diseases in a population of patients with primary Sjögren’s syndrome. Ann Rheum Dis. 2005;64:1062–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Heaton J. Sjögren’s syndrome and systemic lupus erythematosus. BMJ. 1959;1:466–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Gilboe I, Kvien T, Uhlig T, et al. Sicca symptoms and secondary Sjögren’s syndrome in ­systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with ­disease variables. Ann Rheum Dis. 2001;60:1103–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Scofield RH, Bruner GR, Harley JB, et al. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren’s syndrome in familial systemic lupus. Ann Rheum Dis. 2007;66:410–3.PubMedCrossRefGoogle Scholar
  6. 6.
    Pan HF, Ye DQ, Wang Q, et al. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients. Clin Rheumatol. 2008;27:339–43.PubMedCrossRefGoogle Scholar
  7. 7.
    Moutsopoulos HM, Klippel JH, Pavlides N, et al. Correlative histopathologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. Arthritis Rheum. 1980;23:36–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Andonopoulos AP, Skopuli FN, Dimou GS, et al. Sjögren’s syndrome in patients with ­systemic lupus erythematosus. J Rheumatol. 1990;17:201–4.PubMedGoogle Scholar
  9. 9.
    Jonsson H, Nived O, Sturfeld G. Outcome in systemic lupus erythematosus: a prospective study in patients from a defined population. Medicine (Baltimore). 1989;68:141–50.Google Scholar
  10. 10.
    Nossent JC, Swaak A. Systemic lupus erythematosus VII: impact and frequency of secondary Sjögren’s syndrome. Lupus. 1998;7:231–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Manoussakis MN, Georgopoulou C, Zintzaras E, et al. Sjögren’s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren’s syndrome. Arthritis Rheum. 2004;50:882–91.PubMedCrossRefGoogle Scholar
  12. 12.
    Manthorpe R, Teppo AM, Bendixen G, et al. Antibodies to SS-B in chronic inflammatory connective tissue diseases. Relationship with HLA-Dw2 and HLA-Dw3 antigens in primary Sjögren’s syndrome. Arthritis Rheum. 1982;25:662–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Skopuli FN, Siouna-Fatourou H, Dimou GS, et al. Histologic lesion in labial salivary glands of patients with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol. 1991;72:208–12.CrossRefGoogle Scholar
  14. 14.
    Szanto A, Szodoray P, Kiss E, et al. Clinical, serological, and genetic profiles of patients with associated Sjögren’s syndrome and systemic lupus erythematosus. Hum Immunol. 2006;67:924–30.PubMedCrossRefGoogle Scholar
  15. 15.
    Turkcapar N, Olmez U, Tutkak H, et al. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren’s syndrome. Rheumatol Int. 2006;26:354–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Ramos-Casals M, Brito-Zerón P, Font J. The overlap of Sjögren’s syndrome with other ­systemic autoimmune diseases. Semin Arthritis Rheum. 2007;36:246–55.PubMedCrossRefGoogle Scholar
  17. 17.
    Bloch KJ, Buchanan WW, Wohl MJ, et al. Sjögren’s syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine (Baltimore). 1965;44:187–228.CrossRefGoogle Scholar
  18. 18.
    Coll J, Rives A, Grino MC, et al. Prevalence of Sjögren’s syndrome in autoimmune diseases. Ann Rheum Dis. 1987;46:286–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Uhlig T, Kvien TK, Jensen JL, et al. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58:415–22.PubMedCrossRefGoogle Scholar
  20. 20.
    Andonopoulos AP, Drosos AA, Skopuli FN, et al. Secondary Sjögren’s syndrome in rheumatoid arthritis. J Rheumatol. 1987;14:1098–103.PubMedGoogle Scholar
  21. 21.
    Carmona L, Gonzalez-Alvaro I, Balsa A, et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003;62:897–900.PubMedCrossRefGoogle Scholar
  22. 22.
    Gottenberg J, Mignot S, Nicaise-Rolland P, et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome. Ann Rheum Dis. 2005;64:114–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Moutsopoulos HM, Webber BL, Vlagopoulos TP, et al. Differences in the clinical manifestations of sicca syndrome in the presence of absence of rheumatoid arthritis. Am J Med. 1979;66:733–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Kawashima K, Yoshino S. Differences in the clinical features of Sjögren syndrome in the presence and absence of rheumatoid arthritis. Nippon Ika Daigaku Zasshi – J Nippon Med Sch. 1989;56:31–8.Google Scholar
  25. 25.
    Tsampoulas CG, Skopouli FN, Sartoris DJ, et al. Hand radiographic changes in patients with primary and secondary Sjögren’s syndrome. Scand J Rheumatol. 1986;15:333–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Kroneld U, Halse AK, Jonsson R, et al. Differential immunological aberrations in patients with primary and secondary Sjögren’s syndrome. Scand J Immunol. 1997;45:698–705.PubMedCrossRefGoogle Scholar
  27. 27.
    Witte T, Matthias T, Arnett FC, et al. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren’s syndrome. Systemic lupus erythematosus. J Rheumatol. 2000;27:2617–20.PubMedGoogle Scholar
  28. 28.
    Willeke P, Gaubitz M, Schotte H, et al. Clinical and immunological characteristics of patients with Sjögren’s syndrome in relation to alpha-fodrin antibodies. Rheumatology. 2007;46:479–83.PubMedCrossRefGoogle Scholar
  29. 29.
    Ruiz-Tiscar JL, Lopez-Longo FJ, Sanchez-Ramon S, et al. Prevalence of IgG anti-alpha-fodrin antibodies in Sjögren’s syndrome. Ann N Y Acad Sci. 2005;1050:210–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Chen Q, Li X, Zhang H, et al. The epitope study of alpha-fodrin autoantibody in primary Sjögren’s syndrome. Clin Exp Immunol. 2007;149:497–503.PubMedCrossRefGoogle Scholar
  31. 31.
    Nozawa K, Ikeda K, Satoh M, et al. Autoantibody to NA14 is an independent marker primarily for Sjögren’s syndrome. Front Biosci. 2009;14:3733–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Mattey DL, Gonzalez-Gay MA, Hajeer AH, et al. Association between HLA-DRB1*15 and secondary Sjögren’s syndrome in patients with rheumatoid arthritis. J Rheumatol. 2000;27:2611–6.PubMedGoogle Scholar
  33. 33.
    Vitali C, Tavoni A, Rizzo G, et al. HLA antigens in Italian patients with primary Sjögren’s syndrome. Ann Rheum Dis. 1986;45:412–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Moutsopoulos HM, Mann DL, Johnson AH, et al. Genetic differences between primary and secondary sicca syndrome. N Engl J Med. 1979;301:761–3.PubMedCrossRefGoogle Scholar
  35. 35.
    Papasteriades CA, Skopouli FN, Drosos AA, et al. HLA-alloantigen associations in Greek patients with Sjögren’s syndrome. J Autoimmun. 1988;1:85–90.PubMedCrossRefGoogle Scholar
  36. 36.
    Wilson RW, Provost TT, Bias WB, et al. Sjögren’s syndrome: influence of multiple HLA-D region allogens on clinical and serological expression. Arthritis Rheum. 1984;27:1245–53.PubMedCrossRefGoogle Scholar
  37. 37.
    Manthorpe R, Morling N, Platz P, et al. HLA-D antigen frequencies in Sjögren’s syndrome. Differences between the primary and secondary form. Scand J Rheumatol. 1981;10:124–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Warlow RS, Kay PH, McCluskey J, et al. Secondary Sjögren’s syndrome and chromosome six markers. Tissue Antigens. 1985;25:247–54.PubMedCrossRefGoogle Scholar
  39. 39.
    Cipoletti JF, Buckingham RB, Barnes EL, et al. Sjögren’s syndrome in progressive systemic sclerosis. Ann Intern Med. 1977;87:535–41.PubMedGoogle Scholar
  40. 40.
    Osial Jr TA, Whiteside TL, Buckingham RB, et al. Clinical and serological study of Sjögren’s syndrome in patients with progressive systemic sclerosis. Arthritis Rheum. 1983;26:500–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Sjögren’s syndrome in progressive systemic sclerosis. J Rheumatol. 1988;15:965–8.PubMedGoogle Scholar
  42. 42.
    Alarcon-Segovia D, Ibañez G, Hernandez-Ortiz J, et al. Sjögren’s syndrome in progressive systemic sclerosis. Am J Med. 1974;57:78–85.PubMedCrossRefGoogle Scholar
  43. 43.
    Drosos AA, Pennec YL, Elisaf M, et al. Sjögren’s syndrome in patients with the CREST variant of progressive systemic scleroderma. J Rheumatol. 1991;18:1685–8.PubMedGoogle Scholar
  44. 44.
    Oddis CV, Eisenbeis Jr CH, Reidbord HE, et al. Vasculitis in systemic sclerosis: association with Sjögren’s syndrome and the CREST syndrome variant. J Rheumatol. 1987;14:942–8.PubMedGoogle Scholar
  45. 45.
    Andonopoulos AP, Drosos AA, Skopuli FN, et al. Sjögren’s syndrome in rheumatoid arthritis and progressive systemic sclerosis: a comparative study. Clin Exp Rheumatol. 1989;7:203–5.PubMedGoogle Scholar
  46. 46.
    Avouac J, Sordet C, Depinay C, et al. Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006;54:2243–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Salliot C, Mouthon L, Ardizzone M, Sibilia J, et al. Sjögren’s syndrome is associated with and not secondary to systemic sclerosis. Rheumatology. 2007;46:321–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Swaminathan S, Goldblatt F, Dugar M, et al. Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis. Intern Med J. 2008;38:897–903.PubMedCrossRefGoogle Scholar
  49. 49.
    Wangkaew S, Kasitanon N, Sivasomboon C, et al. Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables. Asian Pac J Allergy Immunol. 2006;24:213–21.PubMedGoogle Scholar
  50. 50.
    Hida A, Kawabe Y, Kawakami A, et al. HTLV-I associated Sjögren’s syndrome is ­aetiologically distinct from anti-centromere antibodies positive Sjögren’s syndrome. Ann Rheum Dis. 1999;58:320–2.PubMedCrossRefGoogle Scholar
  51. 51.
    Ramos-Casals M, Nardi N, Brito-Zeron P, et al. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006;35:312–21.PubMedCrossRefGoogle Scholar
  52. 52.
    Salliot C, Gottenberg JE, Bengoufa D, et al. Anticentromere antibodies identify patients with Sjögren’s syndrome and autoimmune overlap syndrome. J Rheumatol. 2007;34:2253–8.PubMedGoogle Scholar
  53. 53.
    Black C, Isenberg DA. Mixed connective tissue disease – goodbye to all that. Rheumatology. 1992;31:695–700.CrossRefGoogle Scholar
  54. 54.
    Ohtsuka E, Nonaka S, Shingu M, et al. Sjögren’s syndrome and mixed connective tissue disease. Clin Exp Rheumatol. 1992;10:339–44.PubMedGoogle Scholar
  55. 55.
    Setty YN, Pittman CB, Mahale AS, et al. Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease. J Rheumatol. 2002;29:487–9.PubMedGoogle Scholar
  56. 56.
    Young C, Hunt S, Watkinson A, et al. Sjögren’s syndrome, cavitating lung disease and high sustained levels of antibodies to serine proteinase 3. Scand J Rheumatol. 2000;29:267–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Radaelli F, Meucci G, Spinzi G, et al. Acute self-limiting jejunitis as the first manifestation of microscopic polyangiitis associated with Sjögren’s disease: report of one case and review of the literature. Eur J Gastroenterol Hepatol. 1999;11:931–4.PubMedCrossRefGoogle Scholar
  58. 58.
    Drosos AA, Constantopoulos SH, Psychos D, et al. The forgotten cause of sicca complex; sarcoidosis. J Rheumatol. 1989;16:1548–51.PubMedGoogle Scholar
  59. 59.
    Ramos-Casals M, Brito-Zeron P, Garcia-Carrasco M, et al. Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore). 2004;83:85–95.CrossRefGoogle Scholar
  60. 60.
    Giotaki H, Constantopoulos SH, Papadimitriou CS, et al. Labial minor salivary gland biopsy: a highly discriminatory diagnostic method between sarcoidosis and Sjögren’s syndrome. Respiration. 1986;50:102–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Jara L, Navarro C, Brito-Zerón P, et al. Thyroid disease in Sjögren’s syndrome. Clin Rheumatol. 2007;26:1601–6. Epub 2007 Jun 9.PubMedCrossRefGoogle Scholar
  62. 62.
    Pérez EB, Kraus A, López G, et al. Autoimmune thyroid disease in primary Sjögren’s syndrome. Am J Med. 1995;99:480–4.PubMedCrossRefGoogle Scholar
  63. 63.
    Kelly C, Foster H, Pal B, et al. Primary Sjögren’s syndrome in north east England – a longitudinal study. Br J Rheumatol. 1991;30:437–42.PubMedCrossRefGoogle Scholar
  64. 64.
    D’Arbonneau F, Ansart S, Le Berre R, et al. Thyroid dysfunction in primary Sjögren’s syndrome: a long-term follow-up study. Arthritis Rheum. 2003;49:804–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Ramos-Casals M, Garcia-Carasco M, Cervera R, et al. Thyroid disease in primary Sjögren syndrome. Study in a series of 160 patients. Medicine (Baltimore). 2000;79:103–8.CrossRefGoogle Scholar
  66. 66.
    Hansen BU, Ericsson UB, Henricsson V, et al. Autoimmune thyroiditis and primary Sjögren’s syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol. 1991;9:137–41.PubMedGoogle Scholar
  67. 67.
    Biro E, Szekanecz Z, Czirjak L, et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol. 2006;25:240–5.PubMedCrossRefGoogle Scholar
  68. 68.
    Tunc R, Gonen MS, Acbay O, et al. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjögren’s syndrome: a case-control study. Ann Rheum Dis. 2004;63:575–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto’s thyroiditis. Clin Endocrinol. 1991;34:383–6.CrossRefGoogle Scholar
  70. 70.
    Szanto A, Csipo I, Horvath I, et al. Autoantibodies to alpha-fodrin in patients with Hashimoto thyroiditis and Sjögren’s syndrome: possible markers for a common secretory disorder. Rheumatol Int. 2008;28:1169–72.PubMedCrossRefGoogle Scholar
  71. 71.
    Cristiansson J. Corneal changes in a case of hepatitis. Acta Ophthalmol. 1954;32:161.Google Scholar
  72. 72.
    Iltanen S, Collin P, Korpela M, et al. Celiac disease and markers of celiac disease latency in patients with primary Sjögren’s syndrome. Am J Gastroenterol. 1999;94:1042–6.PubMedGoogle Scholar
  73. 73.
    Szodoray P, Barta Z, Lakos G, et al. Coeliac disease in Sjögren’s syndrome – a study of 111 Hungarian patients. Rheumatol Int. 2004;24:278–82.PubMedCrossRefGoogle Scholar
  74. 74.
    Luft LM, Barr SG, Martin LO, et al. Autoantibodies to tissue transglutaminase in Sjögren’s syndrome and related rheumatic diseases. J Rheumatol. 2003;30:2613–9.PubMedGoogle Scholar
  75. 75.
    Roth E, Theander E, Londos E, et al. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren’s syndrome, multiple sclerosis and Alzheimer’s disease. Scand J Immunol. 2008;67:626–31.CrossRefGoogle Scholar
  76. 76.
    Collin P, Reunala T, Pukkala E, et al. Coeliac disease–associated disorders and survival. Gut. 1994;35:1215–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • James E. Peters
    • 1
  • David A. Isenberg
    • 1
  1. 1.Department of RheumatologyUniversity College London HospitalLondonUK

Personalised recommendations